Clinical Trial Update: Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing topical fibrinogen-depleted human platelet lysate versus placebo for moderate to severe dry eye, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Topical fibrinogen-depleted human platelet lysate

Snippet

Sponsor: Cambium Bio Limited | Conditions: Dry Eye Disease, Dry Eye | Phase 3 | Status: NOT_YET_RECRUITING